ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Grunsven, P.
Right arrow Articles by van Weel, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Grunsven, P.
Right arrow Articles by van Weel, C
Eur Respir J 1998; 11: 1178-1181
Copyright © ERS Journals Ltd 1998


Original Articles

The role of "fear of corticosteroids" in nonparticipation in early intervention with inhaled corticosteroids in asthma and COPD in general practice

PM van Grunsven, CP van Schayck, HJ van Kollenburg, K van Bosheide, HJ van den Hoogen, J Molema, and C van Weel

Treatment of chronic airflow obstruction with inhaled corticosteroids at an early stage has been shown to preserve the lung function. We tested the hypothesis that "fear of corticosteroids" may be an important reason for nonparticipation in the Detection, early Intervention and Monitoring programme on Chronic obstruction pulmonary disease (COPD) and Asthma ("DIMCA") project. One thousand seven hundred and forty nine adult subjects from 10 general practices were invited to participate in the several parts of the "DIMCA" programme. Refusers were questioned about the reason(s) for nonparticipation. Together the screening, monitoring and three drug interventions of the study showed on average 25-35% refusers. The most frequent reasons for nonparticipation were absence of pulmonary symptoms and lack of time. For those invited to take part in one of the three drug interventions, "dislike of medication" was the most important reason for nonparticipation (33, 45 and 67% of the refusers). "Fear of corticosteroids" specifically was the reason for nonparticipation in 8% of the refusers on the basis of "dislike of medication". We concluded that a specific fear of corticosteroids was not a major obstacle for early intervention with inhaled corticosteroids.


This article has been cited by other articles:


Home page
ERRHome page
L. M. Osman and M. E. Hyland
Patient needs and medication styles in COPD
Eur. Respir. Rev., December 1, 2005; 14(96): 89 - 92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. VAN DEN BOOM, M. P. M. H. RUTTEN-VAN MOLKEN, J. MOLEMA, P. R. S. TIRIMANNA, C. VAN WEEL, and C. P. VAN SCHAYCK
The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 {micro}g Twice a Day in Subjects with Obstructive Airway Disease . Results of the DIMCA Program
Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2057 - 2066.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Muntner, P. Sudre, C. Uldry, T. Rochat, C. Courteheuse, A.-F. Naef, and T. V. Perneger
Predictors of Participation and Attendance in a New Asthma Patient Self-Management Education Program
Chest, September 1, 2001; 120(3): 778 - 784.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
B. Thoonen and C. van Weel
Self management in asthma care
BMJ, December 16, 2000; 321(7275): 1482 - 1483.
[Full Text]


Home page
ThoraxHome page
C P van Schayck, F M M A van der Heijden, G van den Boom, P R S Tirimanna, and C L A van Herwaarden
Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project
Thorax, July 1, 2000; 55(7): 562 - 565.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. van den BOOM, C. P. van SCHAYCK, M. P. M. H. RUTTEN-van MOLKEN, P. R. S. TIRIMANNA, J. J. den OTTER, P. M. van GRUNSVEN, M. J. BUITENDIJK, C. L. A. van HERWAARDEN, and C. van WEEL
Active Detection of Chronic Obstructive Pulmonary Disease and Asthma in the General Population . Results and Economic Consequences of the DIMCA Program
Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1730 - 1738.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.